A phase I trial of BNC105P and ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia.

ABSTRACT:

SUBMITTER: Pooler DB 

PROVIDER: S-EPMC9713021 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature